Delivery Order SPE2DB20D2002-SPE2DB23FL16K
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,561,853,755 units of the pharmaceutical product Ondansetron ODT 4 mg tablets. The contract is a firm-fixed-price delivery order with a ceiling value of $3,962.87 and a performance period through August 18, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued...
- This is a Delivery Order (SPE2DB23FG3QD) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The order is for 4,562,252,301 units of Ondansetron HCL 4 mg Tablets, with a Firm Fixed Price ceiling value of $5,241.97 and a completion date of September 21, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ondansetron HCL 8 mg tablets. The contract has a ceiling value of $4,476.31 and a completion date of December 19, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as the primary...
- The U.S. government agency the Defense Logistics Agency (DLA) Troop Support Medical has awarded a $11,980.91 firm-fixed-price delivery order (SPE2DX23F2HZY) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,560,975,954 units of 4 mg Ondansetron HCL tablets. The delivery order has a completion date of May 19, 2023 and was awarded on May 18, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,894,816 units of the prescription drug Ondansetron HCL 4 mg tablet. The award has a ceiling value of $19,139.11 and a completion date of February 10, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,361.64 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,563,789,214 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of February 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,513,428 units of Ondansetron ODT 8 mg tablets, which are used to treat nausea and vomiting. The contract has a ceiling value of $13,846.35 and a period of performance ending on May 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,560,616,544 units of Ondansetron ODT 4 mg tablets in 30-count packages. The award has a ceiling value of $1,902.33 and an ultimate completion date of April 18, 2023. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of Ondansetron HCL 8 mg tablets. The fixed-price contract has a ceiling value of $1,472.38 and an ultimate completion date of January 8, 2024. This delivery order is placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ondansetron HCL 4 mg tablets. The firm fixed price contract has a ceiling value of $4,020.04 and a completion date of March 8, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as the...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB23FL16KDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,559,785,987 units of the medication Ondansetron HCL 8 mg tablets. The contract has a ceiling value of $2,998.85 and a completion date of February 1, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order was awarded through full and open competition, with no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 1/31/23 |